参考文献/References:
[1] Rossi S,Fornari F,Buscarini L.Percutaneous ultrasoundguided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma[J].J Interv Radiol,1993,8:97-103.
[2]孙文兵.射频消融治疗肝细胞癌三十年:学术地位困境与展望[J].中华肝胆外科杂志,2020,26:401-405.
Sun WB.Radiofrequency ablation of hepatocellular carcinoma for 30 years:the plight of academic status and the prospect[J].Chin J Hepatobiliary Surg,2020,26:401-405.
[3]Qijun S,Xudong M,Yujie C,et al.Health economic analysis and medical cost analysis of children with severe hepatitis B in China:a retrospective study from 2016 to 2022[J].Chin Med J,2025,138:562-567.
[4]Kudo M,Hasegawa K,Kawaguchi Y,et al.A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma(SURF trial):analysis of overall survival[J].J Clin Oncol,2021,39:4093.
[5]Zhong JH,Xing BC,Zhang WG,et al.Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma:retrospective multicentre study[J].Br J Surg,2021,109:71-78.
[6]Feng Q,Chi Y,Liu Y,et al.Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma:a meta-analysis of 23 studies[J].J Cancer Res Clin Oncol,2015,141:1-9.
[7]Zhuang BW,Li W,Wang W,et al.Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria:a population-based study[J].Eur Radiol,2021,31:5379-5389.
[8]Shaaban Abdelgalil M,Amer BE,Yasen N,et al.Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma:an updated meta-analysis and meta-regression of observational studies[J].World J Surg Oncol,2024,22:47.
[9]Peng ZW,Lin XJ,Zhang YJ,et al.Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller:a retrospective comparative study[J].Radiology,2012,262:1022-1033.
[10]Livraghi T,Meloni F,Di Stasi M,et al.Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis:is resection still the treatment of choice?[J].Hepatology,2008,47:82-89.
[11]Rhim H,Lim HK.Radiofrequency ablation of hepatocellular carcinoma:pros and cons[J].Gut Liver,2010,4 Suppl 1:S113-118.
[12]Cheng Y,Shang Y,Zhang S,et al.The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues:a narrative review[J].Cancer Biol Med,2024,21:1120-1140.
[13]Xu Q,Kobayashi S,Ye X,et al.Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma:a meta-analysis of 16 103 patients[J].Sci Rep,2014,4:7252.
[14]中国医师协会肝癌专业委员会.肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J].中华消化外科杂志,2024,23:153-164.
Chinese Professional Committee for Liver Cancer.Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion(2024 edition)[J].Chin J Dig Surg,2024,23:153-164.
[15]Shindoh J,Kobayashi Y,Kawamura Y,et al.Microvascular invasion and a size cutoff value of 2 cm predict long-term oncological outcome in multiple hepatocellular carcinoma:reappraisal of the American joint committee on cancer staging system and validation using the surveillance,epidemiology,and end-results database[J].Liver Cancer,2020,9:156-166.
[16]Zhou JM,Zhou CY,Chen XP,et al.Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion:a prospective cohort study[J].World J Gastrointest Oncol,2021,13:2190-2202.
[17]Kluger MD,Salceda JA,Laurent A,et al.Liver resection for hepatocellular carcinoma in 313 Western patients:tumor biology and underlying liver rather than tumor size drive prognosis[J].J Hepatol,2015,62:1131-1140.
[18]李敏朋,许 斌,俞 渊,等.超声引导经皮肝穿刺射频消融术治疗老年膈肌顶部原发性小肝癌77例[J].山东医药,2021,61:59-62.
Li MP,Xu B,Yu Y,et al.Ultrasound-guided percutaneous radiofrequency ablation for elderly patients with small hepatocellular carcinoma at the diaphragmatic dome:a report of 77 cases[J].Shandong Med J,2021,61:59-62.
[19]张 辉,段小辉,毛先海,等.背侧肝右静脉优先入路腹腔镜解剖性肝Ⅶ段切除肝细胞癌一例[J].中华肝胆外科杂志,2020,26:224-225.
Zhang H,Duan XH,Mao XH,et al.Laparoscopic anatomical hepatectomy of segment Ⅶ for hepatocellular carcinoma by the dorsal right hepatic vein first approach:a case report[J].Chin J Hepatobiliary Surg,2020,26:224-225.
[20]张聚硕.手术辅助系统中虚实配准技术研究[D].河北大学,2025.
Zhang JS.Research on virtual-reality registration technology in surgical assistance system[D].Hebei University,2025.
[21]曹 君,陈亚进.腹腔镜解剖性肝切除治疗肝癌的规范与思考[J].外科理论与实践,2022,27:123-127.
Cao J,Chen YJ.Norms and considerations for laparoscopic anatomical hepatectomy in hepatocellular carcinoma treatment[J].J Surg Concepts Pract,2022,27:123-127.
[22]《中华消化外科杂志》编辑委员会,中国研究型医院学会肝胆胰外科专业委员会.腹腔镜门静脉流域解剖性肝切除理论及技术标准中国专家共识(2023版)[J].中华消化外科杂志,2023,22:1385-1397.
Editorial Board of Chinese Journal of Digestive Surgery.Chinese expert consensus on the theoretical and technical system of laparoscopic portal territory staining guided anatomic liver resection(2023 edition)[J].Chin J Dig Surg,2023,22:1385-1397.
[23]金浩生,石 宁,陈振荣,等.南方医科大学附属广东省人民医院(广东省医学科学院)Glisson系统为中心腹腔镜肝切除临床应用进展[J].中国实用外科杂志,2023,43:465-469.
Jin HS,Shi N,Chen ZR,et al.Application of glisson system centered concept in laparoscopic hepatectomy[J].Chin J Pract Surg,2023,43:465-469.
[24]朱帆东,杨 晨,赵振华.影像组学对评估肿瘤微波/射频消融疗效预后的研究进展[J].介入放射学杂志,2024,33:693-696.
Zhu FD,Yang C,Zhao ZH.Research progress in radiomics evaluation of the efficacy and prognosis of microwave/radiofrequency ablation treatment for tumors[J].J Interv Radiol,2024,33:693-696.
[25]陈天佑,袁 敏,周 粟,等.3.0 T动态增强磁共振灌注成像对小肝癌射频消融疗效评估的价值研究[J].介入放射学杂志,2022,31:154-159.
Chen TY,Yuan M,Zhou S,et al.Value of 3.0 T dynamic contrast-enhanced MRI perfusion imaging in evaluating the efficacy of radiofrequency ablation for small hepatocellular carcinoma[J].J Interv Radiol,2022,31:154-159.
[26]孟庆华.《肝癌转化治疗中肝功能全程管理中国专家共识(2022版)》解读[J].肝癌电子杂志,2024,11:104-108.
Meng QH.Interpretation of “Chinese expert consensus on comprehensive liver function management in conversion therapy for hepatocellular carcinoma(2022)”[J].Electron J Liver Cancer,2024,11:104-108.
[27]Qin S,Chen M,Cheng AL,et al.Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma(IMbrave050):a randomised,open-label,multicentre,phase 3 trial[J].Lancet,2023,402:1835-1847.
[28]Duan X,Wang M,Han X,et al.Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice[J].Cell Cycle,2020,19:3595-3607.
[29]Rozeman EA,Prevoo W,Meier MAJ,et al.Phase Ⅰb/Ⅱtrial testing combined radiofrequency ablation and ipilimumab in uveal melanoma(SECIRA-UM)[J].Melanoma Res,2020,30:252-260.
[30]陈 欢.光子晶体在环境有机污染物快速检测分析中的应用研究[D].郑州大学,2024.
Chen H.Application of photonic crystals in rapid detection and analysis of environmental organic pollutants[D].Zhengzhou Univ,2024.
(收稿日期:2024-11-19)
(本文编辑:茹 实)
相似文献/References:
[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].J Intervent Med,2010,(10):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].J Intervent Med,2010,(10):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].J Intervent Med,2010,(10):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].J Intervent Med,2010,(10):535.
[5]蒲红.上海市第二届射频消融疑难病例研讨会纪要[J].介入放射学杂志,1997,(01):63.
[6]蒲红,尹炯,王咏梅,等.显性间隔房室旁路的射频消融[J].介入放射学杂志,1997,(02):104.
[7]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].J Intervent Med,2005,(10):442.
[8]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[9]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[10]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].J Intervent Med,2009,(10):185.